Your browser doesn't support javascript.
loading
Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers.
Gleicher, Stephanie; Kauffman, Eric C; Kotula, Leszek; Bratslavsky, Gennady; Vourganti, Srinivas.
Afiliación
  • Gleicher S; Department of Urology, SUNY Upstate Medical University, Syracuse, New York.
  • Kauffman EC; Departments of Urology and Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York.
  • Kotula L; Department of Urology, SUNY University of Buffalo, Buffalo, New York.
  • Bratslavsky G; Department of Urology, SUNY Upstate Medical University, Syracuse, New York.
  • Vourganti S; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York.
Prostate ; 76(13): 1135-45, 2016 09.
Article en En | MEDLINE | ID: mdl-27225637
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Mutación de Línea Germinal / Proteína BRCA2 / Heterocigoto Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Animals / Humans / Male Idioma: En Revista: Prostate Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Mutación de Línea Germinal / Proteína BRCA2 / Heterocigoto Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Animals / Humans / Male Idioma: En Revista: Prostate Año: 2016 Tipo del documento: Article